Abstract:Background: It has been demonstrated that the expression of prostate-specific antigen (PSA) is known to not be organ or gender specific but rather a steroid hormone mediated response, and the level of PSA is elevated in the serum of women with hyperandrogenic syndromes. The urinary profile of PSA in female subjects is less clear. We investigated the expression of urinary PSA in female subjects with Cushing's syndrome and the relationship between urinary PSA and 2 steroid hormonal metabolites, 17-hydroxycorticosteroids (17-OHCS) and 17-ketosteroids (17-KS).Methods: We classified 97 female patients into 1 of 3 groups: Group A (n=37), patients with Cushing's syndrome (n=30), or adrenocortical hyperplasia (n=7); Group B (n=29), patients with primary hyperaldosteronism (n=18) or pheochromocytoma (n=11); and Group C (n=31), patients with non-adrenal diseases, including hypertension (n=12) and Type 2 diabetes (n=19). Patients with Cushing's syndrome or primary hyperaldosteronism were defined by clinical symptoms and laboratory confirmation. Patients with pheochromocytoma were defined by clinical symptoms, laboratory confirmation, and computed tomography or MRI. Patients with non-adrenal diseases were defined by a serum cortisol and plasma adrenocorticotropic hormone (ACTH) level within normal limits. Patients taking any medications in this category were excluded. Biochemical indicators related to the steroid hormonal metabolism, such as 17-OHCS, 17-KS, PSA, and creatinine (Cre) of 24-hour urine in these subjects were measured. The 17-OHCS, 17-KS, and PSA were all adjusted for 24-hour urinary Ore.Results: The 24-hour urinary PSA levels were significantly higher (P<0.0001) in the female patients with Cushing's syndrome (mean +/- SE=17.52 +/- 2.10 mu g/mol Ore) than in the controls (mean +/- SE=4.65 +/- 1.23 mu g/mol Ore). Similarly, there was also a significant difference (P<0.01) between 24-hour urinary 17-KS of the female patients (mean +/- SE=7.17 +/- 0.59 mmol/mol Ore) and the controls (6.17 +/- 0.55 mmol/mol Ore). A correlation was observed between 24-hour urinary PSA level and 24-hour urinary 17-KS concentration (rs=0.720, P<0.01). In Group A, the area under the curve (AUC) value of PSA (0.853, P<0.001) was greater than that of 17-OHCS (0.811, P<0.001) and 17-KS (0.693, P<0.01), respectively. In Group B, the AUC value of PSA (0.722, P<0.01) was greater than that of 17-OHCS (0.663, P>0.01) and 17-KS (0.632, P>0.01), respectively.Conclusions: Urinary PSA was elevated in female patients with Cushing's syndrome. It indicates that urinary PSA may be an additional parameter for a better definition of female " patients suffering from Cushing's syndrome.

Urinary Prostate-Specific Antigen is Elevated in Female Patients with Cushing'S Syndrome

Androgens in Cushing's Syndrome

The 24-Hour Urinary Cortisol/Urinary Creatinine Ratio Helps Differentiate Cushing's Syndrome from Simple Obesity

SAT-370 Clinical Characteristics and Metabolic Features of Patients with Subclinical Cushing's Syndrome and Its Correlation with Cortisol Level

[The Value of Serum Dehydroepiandrosterone Sulfate in Differential Diagnosis of Cushing's Syndrome].

Gas Chromatography–Mass Spectrometry Analysis of Urinary Steroid Metabolomics for Detection of Early Signs of Adrenal Neoplasm Malignancy in Patients with Cushing’s Syndrome

Gender-Specific Differences in Clinical Profile and Biochemical Parameters in Patients with Cushing’s Disease: A Single Center Experience

Association of Tumor Markers with Total Testosterone in the Serum of Women with Polycystic Ovary Syndrome

Expression of Steroidogenic Enzyme in Subclinical Cushing's Syndrome Due to Adrenal Adenomas

[Clinical Characteristics of Primary Aldosteronism with Concurrent Adrenal Cushing's Syndrome].

Metabolic Profile Differences in ACTH-dependent and ACTH-independent Cushing Syndrome

Increased clearance of cortisol by 5beta-reductase in a subgroup of women with adrenal hyperandrogenism in polycystic ovary syndrome

Clinical and Biochemical Characteristics of Cushing′s syndrome: A Retrospective Study

Sex-related differences in Cushing's disease: a systematic review and meta-analysis

MON-188 the Diagnostic Value of DHEAS in Subtyping Patients with Cushing Syndrome

Simultaneous Determination of Steroids and Glucocorticoids in Human Urine by Ultra-High-Performance Liquid Chromatography – Tandem Mass Spectrometry (UPLC–MS/MS)

Metabolic Syndrome in Subclinical Cushing’s Syndrome of Adrenal Incidentaloma

Gender and magnetic resonance imaging classification-related differences in clinical and biochemical characteristics of Cushing's disease: a single-centre study

Prevalence of endocrine disorders in 304 premenopausal women referred with oligomenorrhoea

Cortisol production rate is similarly elevated in obese women with or without the polycystic ovary syndrome